Evaluation of the biological behavior of a specific tumor entity. Includes IHC C-Kit, IHC Ki-67, PCR C-Kit Exon 8, PCR C-Kit Exon 11, and Agnor Special Staining.
Histologic evaluation of postmortem tissues.
Histologic evaluation of postmortem tissues.
Differentiation of a monoclonal/oligoclonal or neoplastic lymphoid proliferation from a reactive and polyclonal or pseudoclonal proliferation by PCR. This assay is recommended for fixed tissue only; for fluid samples see TVMDL referral test #8022, PCR for Antigen Receptor Rearrangement – Cytology Specimen [Referral].
Detection of abnormal prion protein, the suspected causative agent of chronic wasting disease, in either antemortem samples (biopsies of retropharyngeal lymph node, tonsil, or rectal wall), or postmortem samples (retropharyngeal lymph node or obex) by immunohistochemical staining.
Review of previously read histopathology slides.
Immunohistochemical labeling for melan A, PNL-2, TRP-1, TRP-2 as a cocktail.
Test includes analysis of proliferation activity (Ki-67 IHC) and interpretation for melanoma prognosis.
Special slide stain as requested by the client.
Identification of specific tumors by immunohistochemical staining.